pharmacy-benefits managers

Express Scripts is the only one out of the big three PBMs that hasn't yet made an acquisition to directly support a personalized medicine focus. However, the firm has expressed an interest in applying PGx strategies to rein in healthcare costs, and acquiring Medco would bring it such capabilities.

Medco made a $5 million commitment this week to open a new school of pharmacy at New Jersey-based Fairleigh Dickinson University. The school, which will focus heavily on educating pharmacists about personalized medicine, is slated to open its doors in fall 2012.

The study found that when doctors and their patients were educated about PGx-guided dosing for warfarin and tamoxifen in a pharmacy-initiated personalized medicine program, the testing rate increased 45-fold for warfarin and seven-fold for tamoxifen.

The 13 drugs for which CVS Caremark customers will have the option to sign up for genetic testing includes a range of treatments for cancer, HIV, and other indications, but the anticoagulant warfarin is not on the list.

During cost-conscious times, a genetic testing management company is trying to guide employers and healthcare plans on how to implement genetic testing so it yields savings and improves the health of its members.

The funding of comparative effectiveness research in the stimulus package may jumpstart its use in healthcare, but how much personalized medicine will contribute to the effort is not yet known.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.